|
Estradiol Tablets
» Estradiol Tablets contain not less than 90.0 percent and not more than 115.0 percent of the labeled amount of C18H24O2.
Packaging and storage
Preserve in tight, light-resistant containers.
Identification
Place a quantity of finely powdered Tablets, equivalent to about 4 mg of estradiol, in a screw-capped, 20-mL vial. Add 10 mL of chloroform, and sonicate for 2 minutes. Filter through medium-porosity filter paper. Apply 20 µL each of this solution and a Standard solution of USP Estradiol RS in chloroform containing 0.4 mg per mL to a suitable thin-layer chromatographic plate (see Chromatography
Dissolution
Medium:
0.3% sodium lauryl sulfate in water; 500 mL.
Apparatus 2:
100 rpm.
Time:
60 minutes.
Mobile phase
Prepare a suitable degassed and filtered solution of water and acetonitrile (55:45).
Standard solution
Prepare a solution of USP Estradiol RS in methanol having an accurately known concentration of about 0.02 mg per mL. Dilute aliquots of this solution with Medium to obtain a final solution having a concentration approximately equal to the expected concentration of drug in the Medium, assuming 100% dissolution.
Test solution
Use a filtered portion of the solution under test from the dissolution vessel.
Chromatographic system
(see Chromatography
Procedure
Separately inject equal volumes (about 100 µL) of the Standard solution and the Test solution into the chromatograph, record the chromatograms, and measure the areas for the major peaks. Calculate the quantity of C18H24O2 dissolved by comparison of the peak areas obtained from the Test solution and the Standard solution.
Tolerances
Not less than 75% (Q) of the labeled amount of C18H24O2 is dissolved in 60 minutes.
Uniformity of dosage units
Chromatographic purity
Solution A
Prepare a degassed mixture of water and acetonitrile (8:2).
Solution B
Prepare a degassed mixture of acetonitrile and water (8:2).
Diluent
Prepare a mixture of water and acetonitrile (6:4).
Mobile phase
Use variable mixtures of Solution A and Solution B as directed for Chromatographic system. Make adjustments if necessary (see System Suitability under Chromatography
System suitability solution
Dissolve accurately weighed quantities of USP Estradiol RS and USP Estrone RS in acetonitrile to obtain a solution having concentrations of 0.5 mg per mL and 0.3 mg per mL, respectively. Pipet 2 mL of this solution into a 50-mL volumetric flask, and dilute with Diluent to volume.
Test solution
Transfer a number of Tablets, containing a combined amount of 4 to 8 mg of estradiol based on the label claim, to a suitable flask, add a volume of Diluent equivalent to about 5 mL per each mg of estradiol, swirl until the Tablets are completely disintegrated, then shake for 15 minutes, and allow the solids to settle. Pass a portion of this solution through a 0.45-µm PVDF filter, discarding the first 2 mL of the filtrate. This solution contains about 0.2 mg of estradiol per mL.
Chromatographic system
(see Chromatography
Procedure
Inject a volume (about 10 µL) of the Test solution into the chromatograph, record the chromatogram, and measure the peak responses. Calculate the percentage of each impurity in the portion of Tablets taken by the formula:
100(ri / rs)
in which ri is the peak response for each impurity; and rs is the sum of the responses of all the peaks: not more than 5% of total impurities is found. Disregard any peaks observed in the blank.
Assay
Mobile phase, Internal standard solution, Standard preparation, and Chromatographic system
Proceed as directed in the Assay under Estradiol.
Assay preparation
Weigh and finely powder not fewer than 10 Tablets. Transfer a portion of the powder, equivalent to about 8 mg of estradiol, to a 100-mL volumetric flask. Add 4 mL of water, and swirl. Add 10.0 mL of Internal standard solution and about 60 mL of methanol. Shake by mechanical means for 15 minutes, dilute with methanol to volume, mix, and allow the solids to settle. Filter a portion, discarding the first 10 mL of the filtrate. Mix 5.0 mL of the subsequent filtrate with 5.0 mL of methanol and 10.0 mL of water.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 3106
Pharmacopeial Forum: Volume No. 34(3) Page 596
|